STOCKHOLM, Sweden -- James Hoey has been named CEO of Elekta Holdings with overall responsibility for all of Elekta’s North American legal entities. He will also assume responsibility for Region North America, replacing Joseph Jachinowski who has decided to leave the company for an external position.
James Hoey co-founded IMPAC which was acquired by Elekta in 2005. He has been with the company for 20 years and is a current member of Elekta’s Executive Committee as well as head of Elekta’s software business.
“Joe Jachinowski has made many valuable contributions to the company’s positive development during his time at Elekta. We thank him for his efforts and wish him best of luck in his future endeavors”, says Tomas Puusepp, President and CEO of Elekta.
About Elekta
Elekta is a human care company pioneering significant innovations and clinical solutions for treating cancer and brain disorders. The company develops sophisticated state of the art tools and treatment planning systems for radiation therapy and radiosurgery, as well as workflow enhancing software systems across the spectrum of cancer care.
Stretching the boundaries of science and technology, providing intelligent and resource-efficient solutions that offer confidence to both healthcare providers and patients, Elekta aims to improve, prolong and even save patient lives, making the future possible today.
Today, Elekta solutions in oncology and neurosurgery are used in over 5,000 hospitals globally, and every day more than 100,000 patients receive diagnosis, treatment or follow-up with the help of a solution from the Elekta Group.
Elekta employs around 2,500 employees globally. The corporate headquarter is located in Stockholm, Sweden, and the company is listed on the Nordic Exchange under the ticker EKTAb. For more information about Elekta, please visit www.elekta.com.
This information was brought to you by Cision http://www.cisionwire.com.
Contact:
Elekta AB Stina Thorman, +46 8 587 254 37 / +46 70 778 60 10 Investor Relations, stina.thorman@elekta.com
